These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 18308386

  • 1. PU.1 and CEBPA expression in acute myeloid leukemia.
    D'Alò F, Di Ruscio A, Guidi F, Fabiani E, Greco M, Rumi C, Hohaus S, Voso MT, Leone G.
    Leuk Res; 2008 Sep; 32(9):1448-53. PubMed ID: 18308386
    [Abstract] [Full Text] [Related]

  • 2. The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.
    Federzoni EA, Humbert M, Valk PJ, Behre G, Leibundgut EO, Torbett BE, Fey MF, Tschan MP.
    Br J Haematol; 2013 Mar; 160(6):855-9. PubMed ID: 23252456
    [No Abstract] [Full Text] [Related]

  • 3. PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.
    Bonadies N, Neururer Ch, Steege A, Vallabhapurapu S, Pabst T, Mueller BU.
    Oncogene; 2010 Feb 18; 29(7):1062-72. PubMed ID: 19966852
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T, Takabatake T, Yoshida K, Nitta Y, Nakamura M, Tanaka S, Ichinohe K, Oghiso Y, Tanaka K.
    Exp Hematol; 2008 Jul 18; 36(7):871-85. PubMed ID: 18375040
    [Abstract] [Full Text] [Related]

  • 5. Complexity of miR-223 regulation by CEBPA in human AML.
    Eyholzer M, Schmid S, Schardt JA, Haefliger S, Mueller BU, Pabst T.
    Leuk Res; 2010 May 18; 34(5):672-6. PubMed ID: 20018373
    [Abstract] [Full Text] [Related]

  • 6. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
    Pabst T, Mueller BU.
    Clin Cancer Res; 2009 Sep 01; 15(17):5303-7. PubMed ID: 19706798
    [Abstract] [Full Text] [Related]

  • 7. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    Pabst T, Eyholzer M, Haefliger S, Schardt J, Mueller BU.
    J Clin Oncol; 2008 Nov 01; 26(31):5088-93. PubMed ID: 18768433
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias.
    Inomata M, Takahashi S, Harigae H, Kameoka J, Kaku M, Sasaki T.
    Leuk Res; 2006 Jun 01; 30(6):659-64. PubMed ID: 16271760
    [Abstract] [Full Text] [Related]

  • 11. Capillary gel electrophoresis: a simple method for identification of mutations and polymorphisms in the CEBPA gene in patients with acute myeloid leukaemia.
    Juhl-Christensen C, Bomberg M, Melsvik D, Hokland P, Nyvold CG.
    Eur J Haematol; 2008 Oct 01; 81(4):273-80. PubMed ID: 18616509
    [Abstract] [Full Text] [Related]

  • 12. Activation of the unfolded protein response in human acute myeloid leukemia.
    Schardt JA, Mueller BU, Pabst T.
    Methods Enzymol; 2011 Oct 01; 489():227-43. PubMed ID: 21266233
    [Abstract] [Full Text] [Related]

  • 13. Protein expression and constitutive phosphorylation of hematopoietic transcription factors PU.1 and C/EBP beta in acute myeloid leukemia blasts.
    Iida H, Towatari M, Iida M, Tanimoto M, Kodera Y, Ford AM, Saito H.
    Int J Hematol; 2000 Feb 01; 71(2):153-8. PubMed ID: 10745625
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia.
    Chen PM, Yen CC, Wang WS, Lin YJ, Chu CJ, Chiou TJ, Liu JH, Yang MH.
    Int J Oncol; 2008 Jun 01; 32(6):1335-41. PubMed ID: 18497996
    [Abstract] [Full Text] [Related]

  • 15. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants.
    Siehl JM, Reinwald M, Heufelder K, Menssen HD, Keilholz U, Thiel E.
    Ann Hematol; 2004 Dec 01; 83(12):745-50. PubMed ID: 15340762
    [Abstract] [Full Text] [Related]

  • 16. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.
    Chinen H, Matsuoka K, Sato T, Kamada N, Okamoto S, Hisamatsu T, Kobayashi T, Hasegawa H, Sugita A, Kinjo F, Fujita J, Hibi T.
    Gastroenterology; 2007 Aug 01; 133(2):559-73. PubMed ID: 17681176
    [Abstract] [Full Text] [Related]

  • 17. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
    Mankaï A, Buhé V, Hammadi M, Youinou P, Ghedira I, Berthou C, Bordron A.
    Ann N Y Acad Sci; 2009 Sep 01; 1173():721-8. PubMed ID: 19758221
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription.
    Brown NL, Finnon R, Bulman RA, Finnon P, Moody J, Bouffler SD, Badie C.
    Leuk Res; 2011 Jan 01; 35(1):126-32. PubMed ID: 20638124
    [Abstract] [Full Text] [Related]

  • 20. Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.
    Snaddon J, Smith ML, Neat M, Cambal-Parrales M, Dixon-McIver A, Arch R, Amess JA, Rohatiner AZ, Lister TA, Fitzgibbon J.
    Genes Chromosomes Cancer; 2003 May 01; 37(1):72-8. PubMed ID: 12661007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.